Whether the superior effects of semaglutide and dulaglutide on stroke reduction compared to other GLP-1RAs arise from inherent differences in drug properties or disparities in trial design remains uncertain
Insights from those benefits checks reveal: More patients have coverage than youd think: Close to half of patients (47%) have coverage of GLP-1s for weight loss and, of those, most have coverage of more than one medication
In ConclusionEmpowering Midlife Health Through Blood Sugar and GLP-1 Support Managing blood sugar and supporting GLP-1 production is essential for healthy aging
SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM Trial Committees and Investigators
As postprandial hyperglycemia was observed in intestinal epithelial cell-specific Sirt1 KO mice, SIRTs could be the molecule connecting intestinal NAMPT-mediated NAD + biosynthesis and canonical Wnt signaling to stimulate GLP-1 secretion [31,94] (Figure 2 and Figure 3)
GLP-1 is a type of incretin hormone, meaning its created in the gut and released after eating a meal